Sign up to save your podcasts
Or
Share The Best Investment You’ll Ever Make
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Best Investment You’ll Ever Make
Club E will be joined by Neil Littman, Founder and CEO of Bioverge to discuss investing within the startup and private markets.
Investing in the venture capital asset class is now more accessible than ever. For the first time, retail investors can now invest in high-growth and high impact startups working to solve some of the world’s most challenging problems.
Learning Objectives:
• Learn about the benefits of diversifying your portfolio with alternative assets
• Learn about the latest innovations in the life science and biotech space
• Learn about how you can construct your portfolio with VC-style investments
About Neil:
Neil Littman is the Founder, CEO and General Partner of Bioverge, a highly curated impact investment platform exclusively dedicated to healthcare. Previously, Neil was Vice President of Business Development at Notable Labs through the completion of the company’s $40M Series B. Prior to that, Neil was a healthcare investment banker and worked on transactions totalling over $1 billion. Neil has a Master’s in Biotechnology from Johns Hopkins and an BA in Molecular Biology.
View all episodes
By Rick BrimacombClub E will be joined by Neil Littman, Founder and CEO of Bioverge to discuss investing within the startup and private markets.
Investing in the venture capital asset class is now more accessible than ever. For the first time, retail investors can now invest in high-growth and high impact startups working to solve some of the world’s most challenging problems.
Learning Objectives:
• Learn about the benefits of diversifying your portfolio with alternative assets
• Learn about the latest innovations in the life science and biotech space
• Learn about how you can construct your portfolio with VC-style investments
About Neil:
Neil Littman is the Founder, CEO and General Partner of Bioverge, a highly curated impact investment platform exclusively dedicated to healthcare. Previously, Neil was Vice President of Business Development at Notable Labs through the completion of the company’s $40M Series B. Prior to that, Neil was a healthcare investment banker and worked on transactions totalling over $1 billion. Neil has a Master’s in Biotechnology from Johns Hopkins and an BA in Molecular Biology.